Renaissance Technologies’s Cascadian Therapeutics, Inc. CASC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-81,688
| Closed | -$302K | – | 3735 |
|
|
2017
Q4 | $302K | Buy |
81,688
+17,900
| +28% | +$66.2K | ﹤0.01% | 3023 |
|
|
2017
Q3 | $261K | Sell |
63,788
-5,800
| -8% | -$23.7K | ﹤0.01% | 2937 |
|
|
2017
Q2 | $259K | Buy |
69,588
+51,600
| +287% | +$192K | ﹤0.01% | 2940 |
|
|
2017
Q1 | $74K | Buy |
+17,988
| New | +$74K | ﹤0.01% | 3113 |
|
|
2015
Q4 | – | Sell |
-56,633
| Closed | -$931K | – | 3536 |
|
|
2015
Q3 | $931K | Sell |
56,633
-22,399
| -28% | -$368K | ﹤0.01% | 2418 |
|
|
2015
Q2 | $1.77M | Sell |
79,032
-23,331
| -23% | -$523K | ﹤0.01% | 2142 |
|
|
2015
Q1 | $1M | Buy |
+102,363
| New | +$1M | ﹤0.01% | 2309 |
|
|
2014
Q1 | – | Sell |
-26,117
| Closed | -$276K | – | 3131 |
|
|
2013
Q4 | $276K | Sell |
26,117
-91,777
| -78% | -$970K | ﹤0.01% | 2528 |
|
|
2013
Q3 | $1.46M | Buy |
117,894
+35,211
| +43% | +$435K | ﹤0.01% | 1820 |
|
|
2013
Q2 | $779K | Buy |
+82,683
| New | +$779K | ﹤0.01% | 2049 |
|